CYSLTR2 and malignant colon neoplasm: Therefore, the LTC4/CysLT2R/15-PGDH signalling-mediated downregulation of Hh–GLI1 signalling combined with increased redifferentiation could be an alternative therapeutic treatment in addition to classical chemotherapy for colon cancer patients (Fig. 7d).